ConductScience.org, home

Paper42958367PubMed

CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer.

Liu Y and 9 others. Mol Cancer, 2026.

Cite this record

ConductScience Library. CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer. Papers, record 42958367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42958367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer.
Journal
Mol Cancer
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-31

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYixuan
2Xiao YYu
3Chen YYiran
4Huang CChaoxiong
5Lin FFeifei
6Zhuang QQingyang
7Li HHui
8Lin PPeicheng
9Tang LLirui
10Li JJinluanhttps://orcid.org/0000-0002-3533-898X

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Radiation ToleranceMajor topic
Colorectal NeoplasmsMajor topic
AcetylcarnitineMajor topic
Transcription Factor RelAMajor topic
NF-kappa BMajor topic
Humans
Acetylation
Animals
Mice
Cell Line, Tumor
Xenograft Model Antitumor Assays
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2024Y9615Joint Funds for the innovation of science and Technology, Fujian provincePubMed
2024Y9611Joint Funds for the innovation of science and Technology, Fujian provincePubMed
2021Y9225Joint Funds for the innovation of science and Technology, Fujian provincePubMed
2023Y9450Joint Funds for the innovation of science and Technology, Fujian provincePubMed
2021Y9202Joint Funds for the innovation of science and Technology, Fujian provincePubMed
F2227R-LJ01-01Fujian Research and Training Grants for Youth and Middle-aged Leaders in Healthcare (2022)PubMed

Source PubMed

Download CSV of grants

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134395263A Genome-Scale CRISPR Knock-Out Screen Identifies MicroRNA-5197-5p as a Promising Radiosensitive Biomarker in Colorectal Cancer.Front Oncol2021https://conductscience.org/library/papers/34395263PubMed
238445632Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.Cancer Biol Ther2024https://conductscience.org/library/papers/38445632PubMed
326122185Opportunities and challenges of radiotherapy for treating cancer.Nat Rev Clin Oncol2015https://conductscience.org/library/papers/26122185PubMed
412456660Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.EMBO J2002https://conductscience.org/library/papers/12456660PubMed
535798917Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development.Discov Oncol2022https://conductscience.org/library/papers/35798917PubMed
622257950The diverse and complex roles of NF-κB subunits in cancer.Nat Rev Cancer2012https://conductscience.org/library/papers/22257950PubMed
739528460Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts.Nat Commun2024https://conductscience.org/library/papers/39528460PubMed
826039447Acetyl coenzyme A: a central metabolite and second messenger.Cell Metab2015https://conductscience.org/library/papers/26039447PubMed
920692872Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.Lancet Oncol2010https://conductscience.org/library/papers/20692872PubMed
1024998913Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.Cell Metab2014https://conductscience.org/library/papers/24998913PubMed
1133543577College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.Oncologist2021https://conductscience.org/library/papers/33543577PubMed
1239828731CRAT downregulation promotes ovarian cancer progression by facilitating mitochondrial metabolism through decreasing the acetylation of PGC-1α.Cell Death Discov2025https://conductscience.org/library/papers/39828731PubMed
1325929862The Accomplices of NF-κB Lead to Radioresistance.Curr Protein Pept Sci2015https://conductscience.org/library/papers/25929862PubMed
1429741565Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2018https://conductscience.org/library/papers/29741565PubMed
1538433280NF-κB in biology and targeted therapy: new insights and translational implications.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38433280PubMed
1636658431Acetyl-CoA metabolism in cancer.Nat Rev Cancer2023https://conductscience.org/library/papers/36658431PubMed
1737322433Molecular mechanisms of tumor resistance to radiotherapy.Mol Cancer2023https://conductscience.org/library/papers/37322433PubMed
1817967430NF-kappa B-mediated adaptive resistance to ionizing radiation.Free Radic Biol Med2008https://conductscience.org/library/papers/17967430PubMed
1939457381Molecular Mechanism of Radioresponsiveness in Colorectal Cancer: A Systematic Review.Genes (Basel)2024https://conductscience.org/library/papers/39457381PubMed
2039014491Versatile function of NF-ĸB in inflammation and cancer.Exp Hematol Oncol2024https://conductscience.org/library/papers/39014491PubMed

See all 27 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42958367

GET https://conductscience.org/api/papers/v1/42958367/references?page=2